News and analysis for the global poultry industry.
Industry News & Trends / Business & Markets / Poultry Health & Disease / Pig Health & Disease
on October 24, 2017

Eli Lilly conducting strategic review of Elanco

Parent company says Elanco Animal Health’s value could be maximized through initial public offering, merger or sale

Eli Lilly and Company has launched a strategic review of its subsidiary Elanco Animal Health, the company announced on October 24.

The company, while also announcing its financial results of the third quarter of fiscal year 2017, revealed that it is reviewing strategic alternatives for Elanco Animal Health that…

To view the full article, please register or login.

Advertisement